A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study ID
- NCT06802198
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Abnormal Uterine Bleeding
- Adenomyosis
- Benign Gynecologic Neoplasm
- Endometriosis
- Fibroid Uterus
- Metrorrhagia
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- total hysterectomy — PROCEDURETotal hysterectomy (TH) involves the complete removal of the uterus including the cervix
- subtotal hysterectomy — PROCEDUREsubtotal hysterectomy (STH) preserves the cervix while removing the upper part of the uterus
Study Details
The goal of this randomized clinical trial is to assess the outcomes of total laparoscopic hysterectomy vs subtotal laparoscopic hysterectomy + mini-laparotomy for uterine extraction for benign gynecological conditions in terms of change in quality of life at 36 months after surgery and patient's impression of improvement. The secondary objectives of the study are to assess any differences in terms of peri and postoperative outcomes (postoperative pain, blood loss, hospital stay, intraoperative or short and long-term postoperative complications, long term urinary, bowel and pelvic floor symptoms, prevalence of vaginal cuff dehiscence). Participants will fill the following questionnaires pre-operatively and at the follow up: * Short Form 36 (SF36), * Euro Quality of life 5D-3L (EQ 5D-3L) * Female Sexual Function Index (FSFI) * Patient Global Impression of Improvement (PGI-I) only during the follow-up period.
Key Dates
- First listed
- Jan 31, 2025
- Start date
- Oct 1, 2025
- Status verified
- Jan 2025
- Primary completion
- Feb 1, 2028
- Completion
- Feb 1, 2030
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: patients undergoing total hysterectomyTotal hysterectomy involves the complete removal of the uterus including the cervix
- Experimental: patients undergoing subtotal hysterectomySubtotal hysterectomy involves the removal of the upper part of the uterus preserving the cervix
Primary Outcome Measure
Quality of life and patient's impression of improvement at 36 months after surgery [ Time Frame: 5 years ]
Central Contacts
- Giovanni Panico, MD+390630153567
Find similar trials
Related Studies
- Cardiovascular Disease Risk in Women With EndometriosisEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Endometriosis and Microvascular Dysfunction; Simvastatin and DuaveePHASE4 · Recruiting · Penn State University · New Haven, Connecticut
- Endometriosis and Microvascular Dysfunction: Role of InflammationEARLY_PHASE1 · Recruiting · Penn State University · University Park, Pennsylvania